Latest papers

The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.

Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy.

Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutations.

Diagnostic evaluation of hypertrophic cardiomyopathy in its clinical and preclinical phases.

Berardinelli syndrome. A case report with fatal outcome.

Analyzing pathogenic mutations of C5 domain from cardiac myosin binding protein C through MD simulations.

A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.

The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy.

Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Invited commentary.

Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes.

Familial hypertrophic cardiomyopathy-related cardiac troponin C mutation L29Q affects Ca2+ binding and myofilament contractility.

Familial conduction system disease associated with hypertrophic cardiomyopathy

Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.

Disease-modifying mutations in familial hypertrophic cardiomyopathy: complexity from simplicity.

DNA analysis in inherited cardiomyopathies: current status and clinical relevance.

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.

The Structure of Isolated Cardiac Myosin Thick Filaments from Cardiac Myosin Binding Protein-C Knockout Mice

MYBPC3 gene variations in hypertrophic cardiomyopathy patients in India.

The role of tropomyosin in heart disease.

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype.